NCT05340361Active, not recruiting
Efficacy and Safety of Zotarolimus-eluting Stent Overexpansion With OCT
In vivO Study of assessmeNt for Efficacy and safetY of Zotarolimus-eluting Stent OVERexpansion With Optical Coherence Tomography (ONYSOVER Trial)
Source: ClinicalTrials.gov · Last updated 24 Apr 2026
Brief summary (registry, in English)
Investigators aimed to evaluate efficacy and safety of expansion capacity of zotarolimus-eluting Stent assessed by optical coherence tomography (OCT) in vivo study.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 30 (estimated)
- First submitted
- 17 Apr 2022
- Start date
- 23 Mar 2022
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Yonsei University
- Diseases
- Coronary artery disease
- NCT number
- NCT05340361
What you commit to
- Study type: Observational
- Planned participants: 30
- From 23 Mar 2022 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with hypersensitivity or contraindication to antiplatelet treatment
Other
- Female of childbearing potential, who possibly plans to become pregnant any time after enrollment into this study.
- Patients with a life expectancy shorter than 1 year
Who the study is looking for
- Patients, ≥19 years of age, who were diagnosed with IHD requiring stent implantation for lesion with size discrepancy between proximal and distal reference diameter over 1mm, such as tapered long lesion or bifurcation lesion, confirmed by OCT
- The decision to participate voluntarily in this study and the written consent of the patient
Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Yongin Severance Hospital Coordinator of this site? Confirm its status | Yŏngin | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.